Benefits of local consolidative treatment in oligometastases of solid cancers: a stepwise-hierarchical pooled analysis and systematic review

Abstract We conducted a meta-analysis of articles published in PubMed, MEDLINE, EMBASE, and Cochrane library to investigate the effectiveness of local consolidative therapy (LCT) against oligometastases. Data from randomized controlled trials (RCTs), balanced studies, and all studies combined were a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chai Hong Rim, In-Soo Shin, Sunmin Park, Hye Yoon Lee
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/1fc540aa5eda4a06bad7fa82f8a8219e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1fc540aa5eda4a06bad7fa82f8a8219e
record_format dspace
spelling oai:doaj.org-article:1fc540aa5eda4a06bad7fa82f8a8219e2021-12-02T13:36:42ZBenefits of local consolidative treatment in oligometastases of solid cancers: a stepwise-hierarchical pooled analysis and systematic review10.1038/s41698-020-00141-42397-768Xhttps://doaj.org/article/1fc540aa5eda4a06bad7fa82f8a8219e2021-01-01T00:00:00Zhttps://doi.org/10.1038/s41698-020-00141-4https://doaj.org/toc/2397-768XAbstract We conducted a meta-analysis of articles published in PubMed, MEDLINE, EMBASE, and Cochrane library to investigate the effectiveness of local consolidative therapy (LCT) against oligometastases. Data from randomized controlled trials (RCTs), balanced studies, and all studies combined were analyzed in a hierarchical manner. Pooled analyses of 31 studies (including seven randomized trials) investigating the effectiveness of LCT on overall survival revealed odds ratios of 3.04, 2.56, and 1.41 for all studies, balanced studies, and RCTs, respectively (all p < 0.05). The benefit of LCT was more prominent in patients with non-small cell lung and colorectal cancers than in those with prostate and small cell lung cancers. Moreover, the benefit of LCT was smaller in patients with high metastatic burdens (p = 0.054). In four of 12 studies with available information, additional grade ≥3 toxicities due to LCTs were reported. Overall, LCT is beneficial for patients with oligometastases, although such benefits are less evident in RCTs than in observational studies. Appropriate LCTs should be carefully selected considering their feasibility, disease type, and metastatic burden.Chai Hong RimIn-Soo ShinSunmin ParkHye Yoon LeeNature PortfolioarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Precision Oncology, Vol 5, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Chai Hong Rim
In-Soo Shin
Sunmin Park
Hye Yoon Lee
Benefits of local consolidative treatment in oligometastases of solid cancers: a stepwise-hierarchical pooled analysis and systematic review
description Abstract We conducted a meta-analysis of articles published in PubMed, MEDLINE, EMBASE, and Cochrane library to investigate the effectiveness of local consolidative therapy (LCT) against oligometastases. Data from randomized controlled trials (RCTs), balanced studies, and all studies combined were analyzed in a hierarchical manner. Pooled analyses of 31 studies (including seven randomized trials) investigating the effectiveness of LCT on overall survival revealed odds ratios of 3.04, 2.56, and 1.41 for all studies, balanced studies, and RCTs, respectively (all p < 0.05). The benefit of LCT was more prominent in patients with non-small cell lung and colorectal cancers than in those with prostate and small cell lung cancers. Moreover, the benefit of LCT was smaller in patients with high metastatic burdens (p = 0.054). In four of 12 studies with available information, additional grade ≥3 toxicities due to LCTs were reported. Overall, LCT is beneficial for patients with oligometastases, although such benefits are less evident in RCTs than in observational studies. Appropriate LCTs should be carefully selected considering their feasibility, disease type, and metastatic burden.
format article
author Chai Hong Rim
In-Soo Shin
Sunmin Park
Hye Yoon Lee
author_facet Chai Hong Rim
In-Soo Shin
Sunmin Park
Hye Yoon Lee
author_sort Chai Hong Rim
title Benefits of local consolidative treatment in oligometastases of solid cancers: a stepwise-hierarchical pooled analysis and systematic review
title_short Benefits of local consolidative treatment in oligometastases of solid cancers: a stepwise-hierarchical pooled analysis and systematic review
title_full Benefits of local consolidative treatment in oligometastases of solid cancers: a stepwise-hierarchical pooled analysis and systematic review
title_fullStr Benefits of local consolidative treatment in oligometastases of solid cancers: a stepwise-hierarchical pooled analysis and systematic review
title_full_unstemmed Benefits of local consolidative treatment in oligometastases of solid cancers: a stepwise-hierarchical pooled analysis and systematic review
title_sort benefits of local consolidative treatment in oligometastases of solid cancers: a stepwise-hierarchical pooled analysis and systematic review
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/1fc540aa5eda4a06bad7fa82f8a8219e
work_keys_str_mv AT chaihongrim benefitsoflocalconsolidativetreatmentinoligometastasesofsolidcancersastepwisehierarchicalpooledanalysisandsystematicreview
AT insooshin benefitsoflocalconsolidativetreatmentinoligometastasesofsolidcancersastepwisehierarchicalpooledanalysisandsystematicreview
AT sunminpark benefitsoflocalconsolidativetreatmentinoligometastasesofsolidcancersastepwisehierarchicalpooledanalysisandsystematicreview
AT hyeyoonlee benefitsoflocalconsolidativetreatmentinoligometastasesofsolidcancersastepwisehierarchicalpooledanalysisandsystematicreview
_version_ 1718392661564456960